Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections

Frederick G. Hayden, Albert D. M. E. Osterhaus, John J. Treanor et al. · New England Journal of Medicine · 1997 · 768 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza

Frederick G. Hayden, Robert L. Atmar, M. Schilling et al. · New England Journal of Medicine · 1999 · 517 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

Structure of pentameric human serum amyloid P component

Jonas Emsley, Helen E. White, B.P. O'Hara et al. · Nature · 1994 · 467 citations

Life Sciences, Biochemistry, Molecular Biology +8

Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study

Mika J. Mäkelä, Karlis Pauksens, Timo Rostila et al. · Journal of Infection · 2000 · 180 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease

Kevin R. Murphy, A Eivindson, Karlis Pauksens et al. · Clinical Drug Investigation · 2000 · 109 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12